TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Renapharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
23,143
|
20,288
|
20,153 |
| Financial expenses |
0
|
52
|
21 |
| Earnings before taxes |
3,473
|
4,435
|
4,928 |
| EBITDA |
5,109
|
4,817
|
5,278 |
| Total assets |
26,838
|
29,730
|
24,816 |
| Current assets |
12,534
|
14,566
|
12,991 |
| Current liabilities |
2,702
|
6,491
|
5,151 |
| Equity capital |
20,268
|
17,797
|
13,295 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
75.5%
|
59.9%
|
53.6% |
| Turnover per employee |
5,786
|
5,072
|
5,038 |
| Profit as a percentage of turnover |
15.0%
|
21.9%
|
24.5% |
| Return on assets (ROA) |
12.9%
|
15.1%
|
19.9% |
| Current ratio |
463.9%
|
224.4%
|
252.2% |
| Return on equity (ROE) |
17.1%
|
24.9%
|
37.1% |
| Change turnover |
3,527
|
31
|
4,715 |
| Change turnover % |
18%
|
0%
|
31% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.